US Stocks
/
IN8bio, Inc. Share Price
IN8bio, Inc. Share Price

IN8bio, Inc. Share Price

NASDAQ: INAB | Micro Cap
$1.33
-$0.04 (-2.92%) Last updated on 08 Oct, 2026 | 20:46 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

IN8bio, Inc. Stock Performance

Open
$1.37
Prev. Close
$1.37
Circuit Range
N/A
Day Range
$1.33 - $1.37
Year Range
$0.90 - $2.71
Volume
602
Average Traded
$1.34

IN8bio, Inc. Share Price Today

As of 9 October 2026, IN8bio, Inc.'s share price is $1.33. The stock opened at $1.37, compared to its previous close of $1.37. During today's trading session, IN8bio, Inc.'s share price traded between $1.33 and $1.37, with an average price of $1.35. Over the past 52 weeks, the stock has recorded a high of $2.71 and a low of $0.90. In terms of performance, IN8bio, Inc.'s share price has declined by 10.14% over the last six months and is down 31.09% on a year-on-year basis.

IN8bio, Inc. Share Price Chart

$1.33$1.37
L
Show Current Price
H

IN8bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$5.82M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.89
Revenue (TTM)
$0.00
Return On Equity (TTM)
-101.66%
Profit Margin
N/A
Debt to Equity
0.01
Quarterly Earnings Growth YoY
0.00%

IN8bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2025Sep 2025Dec 2025Mar 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$5.09-$3.85-$4.94-$5.09
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A24.36%-28.31%-3.04%

IN8bio, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$28.52-$30.01-$30.44-$19.44
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-5.22%-1.43%36.14%

About IN8bio, Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

IN8bio, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.45
$1.33
+3.50%
Sep 2026
$1.11
$1.28
+31.12%
Aug 2026
$0.95
$0.98
-15.52%
Jul 2026
$1.43
$1.16
-18.60%
Jun 2026
$1.80
$1.43
-23.80%
May 2026
$1.50
$1.87
+26.35%
Apr 2026
$1.40
$1.48
+1.37%
Mar 2026
$1.73
$1.46
-14.37%
Feb 2026
$1.94
$1.71
-13.45%
Jan 2026
$2.32
$1.97
-15.81%
Dec 2025
$2.06
$2.34
+16.48%
Nov 2025
$1.86
$2.01
+4.09%

INAB Share Price FAQs

What is IN8bio, Inc. share price today?

chevron-up
IN8bio, Inc. share price today is $1.33 as on October 8, 2026 at 8:46 pm IST.

What is the 52 week high and 52 week low of IN8bio, Inc. stock?

chevron-up
The 52 week high of IN8bio, Inc. stock is $2.71, while the 52 week low is $0.90 as of 8 Oct '26.

What is INAB's market capitalisation today?

chevron-up
INAB market capitalisation is $5.82M as of October 9, 2026, at 12:28 am IST.

What is INAB's net income for the last quarter?

chevron-up
INAB's net income for the last quarter is -5.09B USD.

What is the 5 year returns of INAB?

chevron-up
The 5 year returns of INAB is -99.42% as on 8 Oct '26.

What is the high & low stock price of INAB today?

chevron-up
INAB stock price hit a high of $1.37 and low of $1.33 as of 8 Oct '26.

Can I buy INAB shares in India?

chevron-up
Yes. You can buy INAB in India by opening an international trading account.